Last reviewed · How we verify
NCT04555863
haMSter: a Novel Smartphone Communication Tool for People With MS
NA trial testing haMSter smartphone app in M-health in 50 participants. Completed in 1 June 2021.
1 April 2021
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 50 |
| Start date | 1 April 2020 |
| Primary completion | 1 April 2021 |
| Estimated completion | 1 June 2021 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- haMSter smartphone app
Conditions studied
- M-health — all drugs for M-health →
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Medical University of Vienna
Who can join
Eligibility, any sex, with M-health or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone. Endpoints include the adherence to this app and satisfaction with this Intervention.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial.
Altmann P, Ponleitner M, Monschein T, Krajnc N, et al · · 2022 · cited 3× · PMID 36353697 · DOI 10.1177/20552076221135387 -
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study.
Altmann P, Hinterberger W, Leutmezer F, Ponleitner M, et al · · 2021 · cited 3× · PMID 33960949 · DOI 10.2196/25011
Verify or expand the search:
- PubMed search for NCT04555863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for M-health
Currently open trials in the same condition.
- NCT05687968 — Innovative Approaches in Diabetes Care · NA · recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04555863 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 13 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04555863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing